Intermediate-Risk Papillary Thyroid Cancer: Risk Factors for Early Recurrence in Patients with Excellent Response to Initial Therapy

Thyroid ◽  
2018 ◽  
Vol 28 (10) ◽  
pp. 1311-1317 ◽  
Author(s):  
Augusto Enrique Llamas-Olier ◽  
Diana Isabel Cuéllar ◽  
Giancarlo Buitrago
Keyword(s):  
Risk Factors ◽  
Thyroid Cancer ◽  
Cancer Risk ◽  
Papillary Thyroid Cancer ◽  
Early Recurrence ◽  
Initial Therapy ◽  
Intermediate Risk ◽  
Papillary Thyroid ◽  
Cancer Risk Factors ◽  
Thyroid Cancer Risk

Serum osteopontin can improve papillary thyroid cancer risk assessment of Bethesda III thyroid nodules: a preliminary study

2021 ◽  
Author(s):  
Taha Ulutan Kars ◽  
Mustafa Kulaksizoglu ◽  
İbrahim Kılınç
Keyword(s):  
Thyroid Cancer ◽  
Cancer Risk ◽  
Papillary Thyroid Cancer ◽  
Thyroid Nodules ◽  
Cancer Risk Assessment ◽  
Papillary Thyroid ◽  
Operating Characteristics ◽  
Discriminative Performance ◽  
Thyroid Cancer Risk ◽  
Preliminary Study

Objective: Thyroid cancer can be detected in 5–10% of patients with thyroid nodules. Management may be a challenge if fine-needle aspiration biopsy yields Bethesda III findings. Most of these cases undergo surgery and are ultimately found benign. Our aim was to evaluate whether serum osteopontin can accurately estimate thyroid cancer risk in cases with cytologically Bethesda III thyroid nodules and, thereby, decrease the number of unnecessary surgical interventions. Design and Methods: We obtained blood samples of cases with repeated cytologically Bethesda III thyroid nodules before surgery, and followed up the pathology results after thyroidectomy. We evaluated serum osteopontin from 36 patients with papillary thyroid cancer and compared them with 40 benign cases. Results: Serum osteopontin levels in patients with papillary thyroid cancer are significantly higher than in benign cases (mean serum osteopontin: 10.48 ± 3.51 ng/mL vs 6.14 ± 2.29 ng/mL, p<0.001). The area under the receiver operating characteristics curve was 0.851, suggesting that serum osteopontin could have considerable discriminative performance. Conclusions: In our preliminary study, high serum osteopontin levels can predict the risk of papillary thyroid cancer in thyroid nodules with Bethesda III cytology. Further studies are necessary to confirm these findings.

Retrospective Analysis of Thyroid Nodules: Thyroid Cancer Risk Factors in Suzhou, China

2018 ◽  
Vol 64 (03/2018) ◽  
Author(s):  
Chenlu Zhu ◽  
Shuxiang Li ◽  
Xin Gao ◽  
Gengchao Zhu ◽  
Miaoli Song ◽  
...  
Keyword(s):  
Risk Factors ◽  
Thyroid Cancer ◽  
Cancer Risk ◽  
Retrospective Analysis ◽  
Thyroid Nodules ◽  
Cancer Risk Factors ◽  
Thyroid Cancer Risk

Association of exposure to multiple metals with papillary thyroid cancer risk in China

2019 ◽  
Vol 26 (20) ◽  
pp. 20560-20572 ◽  
Author(s):  
Chi Zhang ◽  
Hua-Bing Wu ◽  
Meng-Xia Cheng ◽  
Ling Wang ◽  
Chao-Bing Gao ◽  
...  
Keyword(s):  
Thyroid Cancer ◽  
Cancer Risk ◽  
Papillary Thyroid Cancer ◽  
Papillary Thyroid ◽  
Thyroid Cancer Risk

Abstract #1075: Documentation of Thyroid Cancer Risk Factors in Patients with Thyroid Nodules

2015 ◽  
Vol 21 ◽  
pp. 230
Author(s):  
Rudruidee Karnchanasorn ◽  
Kristine Grdinovac ◽  
Abeer Anabtawi ◽  
G. Chen
Keyword(s):  
Risk Factors ◽  
Thyroid Cancer ◽  
Cancer Risk ◽  
Thyroid Nodules ◽  
Cancer Risk Factors ◽  
Thyroid Cancer Risk
Sign in / Sign up

Export Citation Format

Share Document